Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

aTyr Pharma Inc (NASDAQ:LIFE)

2.90
Delayed Data
As of Jul 22
 -0.06 / -2.03%
Today’s Change
2.48
Today|||52-Week Range
21.00
-70.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Operating ActivitiesNet Income / Starting Line-11.1M-11.3M-16.5M-16.1M
 
 
 
 
 
Depreciation209.0K225.0K226.0K233.0K
 
 
 
 
 
Total Other Cash Flow1.0M1.3M2.7M1.6M
 
 
 
 
 
Funds From Operations-9.9M-9.8M-13.6M-14.3M
 
 
 
 
 
Funds From/For Other Operating Expenses1.4M-306.0K-3.8M-1.8M
 
 
 
 
 
Net Cash Flow - Operating Activities-11.2M-9.5M-9.8M-12.5M
 
 
 
 
 
 
InvestingIncrease In Investments-84.9M-14.5M-10.0M-10.0M
 
 
 
 
 
Decrease In Investments4.0K22.1M14.1M24.7M
 
 
 
 
 
Capital Expenditures-40.0K-382.0K-119.0K-314.0K
 
 
 
 
 
Net Cash Flow Investing-85.0M7.2M3.9M14.4M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings533.0K-533.0K0.000.00
 
 
 
Long Term Debt Reduction-2.8M-815.0K-824.0K-838.0K
 
 
 
 
 
Net Proceeds Stock Sale106.5M564.0K-273.0K11.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing-501.0K0.000.000.00
 
 
Net Cash Flow - Financing104.7M-784.0K-1.1M-827.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash8.6M-3.0M-7.0M1.1M